The strategy of powder-in-capsule has the ability to accelerate the clinical development cycle. David Edwards of Capsugel investigates new developments on the drug market.
The early stage is a critical time during the development life cycle of a new drug. Like a newly hatched tadpole, it has to compete for resources, not only with its tadpole siblings, but with all the others sharing the pond in order to survive. No matter how large it is, the parent drug company has to choose which of its newly hatched drug candidates are best suited to survive and grow in the marketplace, and then direct available resources accordingly.